US2018228649A1PendingUtilityA1
Intraocular delivery devices and methods therefor
Est. expiryApr 2, 2032(~5.7 yrs left)· nominal 20-yr term from priority
Inventors:Leonid E. Lerner
A61F 9/00736A61M 5/3145A61M 5/38A61F 9/0017A61M 5/3243A61M 2210/0612A61M 5/46A61F 9/0026
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Injection devices for delivering pharmaceutical compositions into the eye are described. Some devices include a resistance component for controllably deploying an injection needle through the eye wall. The resistance component may be disposed on a removable injector attachment or on a portion of the injection device housing. Other devices may include a filter for the removal of air, infectious agents, and/or other particulate matter from the composition before the composition is injected into the eye. Related methods and systems comprising the devices are also described.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . An injector configured for single-handed operation, comprising:
a housing; a reservoir within the housing comprising a volume of a therapeutic agent; a plunger configured to slide within the housing and deliver the volume of therapeutic agent via an exit port; a slot extending axially along a sidewall of the housing; and a first actuator that extends through a slot in the sidewall of the housing, the first actuator fixedly attached to a portion of the plunger and configured to slide axially distally along the slot, the first actuator configured to be actuated with a fingertip and move the plunger axially; and a second actuator attached to the proximal end of the plunger and configured to move the plunger axially, the second actuator proximate a proximal end of the syringe.
3 . The injector of claim 2 , wherein the therapeutic agent comprises a VEGF antagonist.
4 . The injector of claim 2 , wherein the injection volume is between about 0.03 mL and about 0.05 mL.
5 . The injector of claim 2 , wherein the injection volume is between about 1 microliters and about 200 microliters.
6 . The injector of claim 2 , wherein a square of the internal drug reservoir radius is proportional to the volume of the reservoir.
7 . The injector of claim 2 , wherein the plunger is configured to travel axially a length of between about 7.7 mm and about 17.7 mm.
8 . The injector of claim 2 , wherein the first actuator comprises a dome shape.
9 . The injector of claim 8 , wherein the dome shape comprises ridges.
10 . A injector configured for single-handed operation, comprising:
a housing; a reservoir within the housing comprising a volume of a therapeutic agent; a plunger configured to slide within the housing and deliver the volume of therapeutic agent via an exit port; a slot extending axially along a sidewall of the housing; and a first actuator that extends through a slot in the sidewall of the housing, the first actuator fixedly attached to a portion of the plunger and configured to slide axially distally along the slot, the first actuator configured to be actuated with a fingertip.
11 . The injector of claim 10 , wherein the therapeutic agent comprises a VEGF antagonist.
12 . The injector of claim 10 , wherein the injection volume is between about 0.03 mL and about 0.05 mL.
13 . The injector of claim 10 , wherein the injection volume is between about 1 microliters and about 200 microliters.
14 . The injector of claim 10 , additionally comprising a second actuator attached to the proximal end of the plunger, the second actuator proximate a proximal end of the injector.
15 . The injector of claim 10 , wherein a square of the internal drug reservoir radius is proportional to the volume of the reservoir.
16 . The injector of claim 10 , wherein the plunger is configured to travel axially a length of between about 7.7 mm and about 17.7 mm.
17 . The injector of claim 10 , wherein the first actuator comprises a dome shape.
18 . The injector of claim 17 , wherein the dome shape comprises ridges.
19 . A pre-filled injector, comprising:
a housing; a reservoir within the housing comprising a volume of a therapeutic agent; a plunger configured to axially slide within the housing and deliver the volume of therapeutic agent via an exit port; a slot extending axially along a sidewall of the housing; and a first actuator that extends through a slot in the sidewall of the housing, the first actuator fixedly attached to a portion of the plunger and configured to slide axially distally along the slot, the first actuator configured to be actuated with a fingertip and move the plunger axially; and a second actuator attached to the proximal end of the plunger and configured to move the plunger axially upon exertion of a force on the actuator in a proximal direction, the second actuator proximate a proximal end of the housing.
20 . The injector of claim 19 , wherein the plunger further comprises a seal on a distal end of the plunger and the slot has a proximal end and a distal end, wherein the seal is distal to the slot throughout an axial working range of the plunger.
21 . The injector of claim 19 , wherein the plunger further comprises a seal on a distal end of the plunger and the slot has a proximal end and a distal end, wherein the seal is distal to the distal end of the slot.Join the waitlist — get patent alerts
Track US2018228649A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.